Early Relapse

general

Clinical and/or laboratory evidence of early reemergence of a disorder after a period of remission.

Centers

Active Trials

$11M

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Early Relapse of Acute Myeloid Leukemia	—	—

Top Centers for Early Relapse(7)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive High-Volume Research Center	High-Volume Research Center	—	$3M	72.1
2	The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory Active Research Program	Active Research Program	—	$3M	67.1
3	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	—	$2M	62.1
4	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	—	$1M	57.1
5	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	—	$1M	52.1
6	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	—	$793K	47.1
7	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	—	$292K	42.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →